In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of ...
Dermatology in the near future will be characterized by digitally enabled, patient-centred research that reaches people where ...
AI is rapidly entering clinical care, but malpractice law has not kept pace. As adoption accelerates, clinicians are being ...
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” or the “Company”), a precision guided biotech/life sciences company focused on advancing ...
Recently, the U.S. Food and Drug Administration (FDA) issued a guidance document entitled Use of Real-World Evidence to Support ...
The U.S. Food and Drug Administration (FDA) has rebuked the founder of Moose Jaw’s controversial Dr. Goodenowe Restorative ...
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced today that our ...
A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...
Systemic inflammation has been elevated to a modifiable cardiovascular risk factor requiring assessment, monitoring, and modification, based on consensus recommendations.
SHANGHAI, SHANGHAI, CHINA, January 26, 2026 /EINPresswire.com/ -- Communication across linguistic boundaries has become ...
Detailed price information for Adia Nutrition Inc (ADIA) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results